OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Save the Date: Boston Will Become a Meeting Place for the Future of GI Oncology

10 Must-Read Posts in GU Oncology This Week

Marina Chiara Garassino Highlights Five-Year Follow-Up Results From the KEYNOTE-671 Trial in Resectable NSCLC

Kevin Donaghy: When Stage IV Melanoma Changed the Meaning of Hope

Lived Experience Advocacy Hub Webinar Opportunity: AI in Oncology

Adagene Completes Phase 2 Enrollment for Muzastotug Plus Pembrolizumab in MSS Colorectal Cancer

Amer Zeidan: Can All-Oral Therapy Reduce the Healthcare Burden for AML Patients?

10 Cancer Research Funding Opportunities to Know This November

Calculators

Khorana Score (Cancer-Associated VTE Risk)

Estimates venous thromboembolism (VTE) risk in ambulatory cancer patients using the validated Khorana score.

Khorana Score Points:

  • Very high-risk site (Stomach, Pancreas): +2
  • High-risk site (Lung, Lymphoma, Gynecologic, Bladder, Testicular): +1
  • Platelets ≥350 ×10⁹/L: +1
  • Hemoglobin <10 g/dL or ESA use: +1
  • WBC >11 ×10⁹/L: +1
  • BMI ≥35 kg/m²: +1

Risk Categories:

  • Low risk: 0 points
  • Intermediate risk: 1-2 points
  • High risk: ≥3 points

Our calculators apply published formulas as precisely as we can. Even so, no formula captures every detail of a real patient. Use the result as one input to your own assessment, not the final word.